Operational scale for personalized medicine
The guest detailed the extraordinary operational challenge Moderna has undertaken to manufacture a unique mRNA medicine for each patient at scale, comparing it favorably to the complexity of CAR-T therapies.
Keep reading this one
You've read the thesis and who argued it. A free account opens the argument, what validates it, the risks the show raised, and the moment in the episode where it was said — 3 ideas in full a day, no card.